Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders | Genetics in Medicine | 2019 | 164 |
Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model | Neuropsychopharmacology | 2019 | 97 |
Mu rhythm desynchronization is specific to action execution and observation: Evidence from time-frequency and connectivity analysis | NeuroImage | 2019 | 69 |
A Multisite Randomized Controlled Two-Phase Trial of the Early Start Denver Model Compared to Treatment as Usual | Journal of the American Academy of Child and Adolescent Psychiatry | 2019 | 68 |
Pilot study of probiotic/colostrum supplementation on gut function in children with autism and gastrointestinal symptoms | PLoS ONE | 2019 | 67 |
Changing conceptualizations of regression: What prospective studies reveal about the onset of autism spectrum disorder | Neuroscience and Biobehavioral Reviews | 2019 | 59 |
Early motor abilities in infants at heightened versus low risk for ASD: A Baby Siblings Research Consortium (BSRC) study | Journal of Abnormal Psychology | 2019 | 53 |
Effectiveness of community-based early intervention for children with autism spectrum disorder: a meta-analysis | Journal of Child Psychology and Psychiatry and Allied Disciplines | 2019 | 50 |
Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation | Genetics in Medicine | 2019 | 43 |
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial | Journal of Inherited Metabolic Disease | 2019 | 38 |
Sibling Recurrence Risk and Cross-aggregation of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder | JAMA Pediatrics | 2019 | 37 |
Costello syndrome: Clinical phenotype, genotype, and management guidelines | American Journal of Medical Genetics, Part A | 2019 | 34 |
Cognitive deficits in the Snord116 deletion mouse model for Prader-Willi syndrome | Neurobiology of Learning and Memory | 2019 | 34 |
Rigor and reproducibility in rodent behavioral research | Neurobiology of Learning and Memory | 2019 | 33 |
Composition of the Intranuclear Inclusions of Fragile X-associated Tremor/Ataxia Syndrome | Acta Neuropathologica Communications | 2019 | 31 |
An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study | Biological Psychiatry | 2019 | 31 |
Association of Maternal Prenatal Vitamin Use With Risk for Autism Spectrum Disorder Recurrence in Young Siblings | JAMA Psychiatry | 2019 | 30 |
Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study | Human Molecular Genetics | 2019 | 25 |
A Longitudinal Study of Local Gyrification Index in Young Boys With Autism Spectrum Disorder | Cerebral Cortex | 2019 | 24 |
Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions | PLoS ONE | 2019 | 23 |
Polychlorinated biphenyls influence on autism spectrum disorder risk in the MARBLES cohort | Environmental Research | 2019 | 21 |
Microglia: An Intrinsic Component of the Proliferative Zones in the Fetal Rhesus Monkey (Macaca mulatta) Cerebral Cortex | Cerebral Cortex | 2019 | 21 |
Whole genome bisulfite sequencing of Down syndrome brain reveals regional DNA hypermethylation and novel disorder insights | Epigenetics | 2019 | 18 |
Severity Assessment in CDKL5 Deficiency Disorder | Pediatric Neurology | 2019 | 18 |
Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature | Cannabis and Cannabinoid Research | 2019 | 18 |